Suppr超能文献

基于生物聚合物纳米的具有抗氧化特性的药物递送系统的最新进展综述:对过去五年的洞察

A Review of Recent Developments in Biopolymer Nano-Based Drug Delivery Systems with Antioxidative Properties: Insights into the Last Five Years.

作者信息

Stevanović Magdalena, Filipović Nenad

机构信息

Group for Biomedical Engineering and Nanobiotechnology, Institute of Technical Sciences of SASA, Kneza Mihaila 35/IV, 11000 Belgrade, Serbia.

出版信息

Pharmaceutics. 2024 May 16;16(5):670. doi: 10.3390/pharmaceutics16050670.

Abstract

In recent years, biopolymer-based nano-drug delivery systems with antioxidative properties have gained significant attention in the field of pharmaceutical research. These systems offer promising strategies for targeted and controlled drug delivery while also providing antioxidant effects that can mitigate oxidative stress-related diseases. Generally, the healthcare landscape is constantly evolving, necessitating the continual development of innovative therapeutic approaches and drug delivery systems (DDSs). DDSs play a pivotal role in enhancing treatment efficacy, minimizing adverse effects, and optimizing patient compliance. Among these, nanotechnology-driven delivery approaches have garnered significant attention due to their unique properties, such as improved solubility, controlled release, and targeted delivery. Nanomaterials, including nanoparticles, nanocapsules, nanotubes, etc., offer versatile platforms for drug delivery and tissue engineering applications. Additionally, biopolymer-based DDSs hold immense promise, leveraging natural or synthetic biopolymers to encapsulate drugs and enable targeted and controlled release. These systems offer numerous advantages, including biocompatibility, biodegradability, and low immunogenicity. The utilization of polysaccharides, polynucleotides, proteins, and polyesters as biopolymer matrices further enhances the versatility and applicability of DDSs. Moreover, substances with antioxidative properties have emerged as key players in combating oxidative stress-related diseases, offering protection against cellular damage and chronic illnesses. The development of biopolymer-based nanoformulations with antioxidative properties represents a burgeoning research area, with a substantial increase in publications in recent years. This review provides a comprehensive overview of the recent developments within this area over the past five years. It discusses various biopolymer materials, fabrication techniques, stabilizers, factors influencing degradation, and drug release. Additionally, it highlights emerging trends, challenges, and prospects in this rapidly evolving field.

摘要

近年来,具有抗氧化性能的生物聚合物基纳米药物递送系统在药物研究领域受到了广泛关注。这些系统为靶向和控释药物递送提供了有前景的策略,同时还具有抗氧化作用,可减轻与氧化应激相关的疾病。一般来说,医疗保健领域在不断发展,需要持续开发创新的治疗方法和药物递送系统(DDSs)。DDSs在提高治疗效果、最小化不良反应和优化患者依从性方面发挥着关键作用。其中,纳米技术驱动的递送方法因其独特的性质,如改善溶解性、控释和靶向递送,而备受关注。纳米材料,包括纳米颗粒、纳米胶囊、纳米管等,为药物递送和组织工程应用提供了多功能平台。此外,基于生物聚合物的DDSs具有巨大的潜力,利用天然或合成生物聚合物来包裹药物并实现靶向和控释。这些系统具有许多优点,包括生物相容性、生物可降解性和低免疫原性。将多糖、多核苷酸、蛋白质和聚酯用作生物聚合物基质进一步提高了DDSs的多功能性和适用性。此外,具有抗氧化性能的物质已成为对抗与氧化应激相关疾病的关键因素,可保护细胞免受损伤和预防慢性疾病。具有抗氧化性能的生物聚合物基纳米制剂的开发是一个新兴的研究领域,近年来出版物数量大幅增加。本综述全面概述了该领域在过去五年中的最新进展。它讨论了各种生物聚合物材料、制备技术、稳定剂、影响降解的因素和药物释放。此外,它还强调了这个快速发展领域中的新兴趋势、挑战和前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08a/11125366/70df6f31b739/pharmaceutics-16-00670-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验